Position in ZTS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,083,739
-$1,902,173 QoQ
Shares Held
84,661
+25.3% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#306
of 1,408 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ODDO BHF ASSET MANAGEMENT SAS holds $7,540,261 across 3 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (80.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
84,661 | $6,083,739 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
8,642 | $1,456,522 | |
| 3 | 5,000,000 | $0 |
All Filings in ZTS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,083,739 | 84,661 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $7,985,912 | 67,557 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $5,972,549 | 47,469 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,391,453 | 36,847 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,642,690 | 42,595 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,508,369 | 45,602 | Shares | Sole | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||